Medicare Enrolled
Dr. David Lau, M.D., PHD
Adult Congenital Heart Disease Physician · New York, NY
Practice pattern: Remote & Electrophysiology
— Practice combining remote and electrophysiology services
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lau from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lau?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lau
Dr. David Lau is an adult congenital heart disease physician in New York, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Lau performed 5,851 Medicare services across 3,077 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lau received a total of $277,370 from 36 pharmaceutical and/or device companies across 870 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in adult congenital heart disease physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lau is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 10% volume in NY
$277,370 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,851
Medicare services
Top 10% in NY for adult congenital heart disease physician
3,077
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~325 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,484 | $75 | $150 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,019 | $12 | $65 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
645 | $64 | $550 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
613 | $23 | $61 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
518 | $149 | $700 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
464 | $179 | $500 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
154 | $114 | $200 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
148 | $42 | $100 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
125 | $4 | $21 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
100 | $52 | $110 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
83 | $226 | $800 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
83 | $140 | $240 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
70 | $133 | $450 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
54 | $169 | $500 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
43 | $67 | $250 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
39 | $17 | $50 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
34 | $22 | $350 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
34 | $111 | $350 |
| Evaluation of implantable heart and blood vessel monitoring system This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity. |
28 | $19 | $45 |
| Ultrasound of arm arteries or grafts An ultrasound exam of the arteries in one arm or any arterial grafts present. This imaging test uses sound waves to visualize blood flow and vessel structure. |
23 | $115 | $400 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
21 | $23 | $250 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
17 | $23 | $45 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
14 | $238 | $500 |
| Echocardiogram for congenital heart defect An ultrasound of the heart used to evaluate for congenital defects. This imaging test uses sound waves to create pictures of the heart's structure and function. |
13 | $199 | $700 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
13 | $47 | $300 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
12 | $64 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.4% high complexity
12.3% medium
76.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$277,370
Total received (2018-2024)
Avg $39,624/year across 7 years
Top 9% in NY for adult congenital heart disease physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
870
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$260,612 (94.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,158 (5.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$600 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,781
2023
$21,659
2022
$45,556
2021
$55,559
2020
$6,003
2019
$62,838
2018
$78,974
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$3,025
Boston Scientific Corporation
$903
Boehringer Ingelheim Pharmaceuticals, Inc.
$550
BIOTRONIK INC.
$483
Novartis Pharmaceuticals Corporation
$472
Amgen Inc.
$316
PFIZER INC.
$246
Merck Sharp & Dohme LLC
$231
Lexicon Pharmaceuticals, Inc.
$156
SANOFI-AVENTIS U.S. LLC
$147
AstraZeneca Pharmaceuticals LP
$99
Lilly USA, LLC
$42
Janssen Pharmaceuticals, Inc
$36
Kiniksa Pharmaceuticals International, plc
$21
SCPHARMACEUTICALS INC.
$20
Novo Nordisk Inc
$20
ABBVIE INC.
$14
Top 3 companies account for 66.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$212,048
E.R. Squibb & Sons, L.L.C.
$42,140
PFIZER INC.
$6,942
Boston Scientific Corporation
$3,490
Novartis Pharmaceuticals Corporation
$1,680
Amarin Pharma Inc.
$1,165
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,125
Esperion Therapeutics, Inc.
$881
BOSTON SCIENTIFIC CORPORATION
$869
Merck Sharp & Dohme LLC
$803
Amgen Inc.
$783
Abbott Laboratories
$742
BIOTRONIK INC.
$662
SANOFI-AVENTIS U.S. LLC
$620
Celgene Corporation
$600
Medtronic, Inc.
$388
AstraZeneca Pharmaceuticals LP
$386
Medtronic Vascular, Inc.
$358
Lexicon Pharmaceuticals, Inc.
$256
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$247
Novo Nordisk Inc
$192
Merck Sharp & Dohme Corporation
$179
Bayer Healthcare Pharmaceuticals Inc.
$145
HeartFlow, Inc.
$145
Regeneron Healthcare Solutions, Inc.
$127
Astellas Pharma US Inc
$90
Lilly USA, LLC
$65
Kowa Pharmaceuticals America, Inc.
$46
SCPHARMACEUTICALS INC.
$37
Azurity Pharmaceuticals, Inc.
$30
IBSA Pharma Inc.
$30
Bayer HealthCare Pharmaceuticals Inc.
$27
BRACCO DIAGNOSTICS INC.
$26
Kiniksa Pharmaceuticals International, plc
$21
ABBVIE INC.
$14
ARBOR PHARMACEUTICALS, INC.
$12
Top 3 companies account for 94.1% of all-time payments
Associated products mentioned in payments ›
Acticor 7 VR-T DX · Adempas · Aimovig · Arcalyst · BIOMONITOR · BRILINTA · CAMZYOS · CARDIOGEN · CHANTIX · CardioMEMS HF System · ELIQUIS · EMBLEM · EMBLEM MRI S-ICD · ENTRESTO · Edarbi · FARXIGA · FFRct · FUROSCIX · GALLANT · GENERAL THERAPIES · GENERAL - THERAPIES · GENERAL THERAPIES · Inpefa · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LICART · LINQ II · LINZESS · LIVALO · LUX-Dx Insertable Cardiac Monitor · Livalo · MOUNJARO · MULTAQ · Micra · Mitra Clip system · Mosaic · NEXLETOL · NEXLIZET · NURTEC ODT · Ozempic · PAMIRA · PRALUENT · PREVNAR 20 · Prolia · RESOLUTE ONYX · RESONATE · Repatha · Resolute · Rybelsus · SILVERHAWK · TRULANCE · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · XARELTO · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in adult congenital heart disease physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for adult congenital heart disease physician in NY.
Geographic Context
Adult congenital heart disease physicians within 10 mi
8
Per 100K population
0.5
County median income
$104,553
Nearest hospital
NY EYE AND EAR INFIRMARY OF MOUNT SINAI
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lau is a remote & electrophysiology specialist, with above-average Medicare volume (top 10% in NY), with speaking/promotional industry engagement in the top 9% of NY peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lau experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Lau performed 1,484 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lau receive payments from pharmaceutical companies?
Yes. Dr. Lau received a total of $277,370 from 36 companies across 870 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lau's costs compare to other adult congenital heart disease physicians in New York?
Dr. Lau's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lau) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Adult Congenital Heart Disease Physicians in New York
Browse adult congenital heart disease physicians in New York ranked by procedure volume and transparency data.
Highest volume
Top Adult Congenital Heart Disease Physicians in NY
Adult congenital heart disease physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Adult Congenital Heart Disease Physicians in NY
Which NY adult congenital heart disease physicians receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology